Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
Public ClinicalTrials.gov record NCT01077700. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-288 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Study identification
- NCT ID
- NCT01077700
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- AbbVie (prior sponsor, Abbott)
- Industry
- Enrollment
- 214 participants
Conditions and interventions
Conditions
Interventions
- ABT-288 Low Dose Drug
- Placebo Drug
- ABT-288 High Dose Drug
Drug
Eligibility (public fields only)
- Age range
- 20 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2010
- Primary completion
- Jun 30, 2011
- Completion
- Jun 30, 2011
- Last update posted
- Jun 5, 2018
2010 – 2011
United States locations
- U.S. sites
- 24
- U.S. states
- 13
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site Reference ID/Investigator# 21662 | Anaheim | California | 92804 | — |
| Site Reference ID/Investigator# 21683 | Garden Grove | California | 92845 | — |
| Site Reference ID/Investigator# 21581 | National City | California | 91950 | — |
| Site Reference ID/Investigator# 45310 | Norwalk | California | 90650 | — |
| Site Reference ID/Investigator# 26400 | Pasadena | California | 91106 | — |
| Site Reference ID/Investigator# 21584 | Pico Rivera | California | 90660 | — |
| Site Reference ID/Investigator# 45312 | Riverside | California | 92506 | — |
| Site Reference ID/Investigator# 45309 | San Diego | California | 92128 | — |
| Site Reference ID/Investigator# 46603 | Plantation | Florida | 33317 | — |
| Site Reference ID/Investigator# 21681 | Chicago | Illinois | 60640 | — |
| Site Reference ID/Investigator# 26397 | Shreveport | Louisiana | 71104-2136 | — |
| Site Reference ID/Investigator# 21761 | Pittsfield | Massachusetts | 01201 | — |
| Site Reference ID/Investigator# 21591 | St Louis | Missouri | 63139 | — |
| Site Reference ID/Investigator# 26409 | Brooklyn | New York | 11235 | — |
| Site Reference ID/Investigator# 21588 | Cedarhurst | New York | 11516 | — |
| Site Reference ID/Investigator# 21589 | Dayton | Ohio | 45417 | — |
| Site Reference ID/Investigator# 26407 | Oklahoma City | Oklahoma | 73103 | — |
| Site Reference ID/Investigator# 21601 | Philadelphia | Pennsylvania | 19131 | — |
| Site Reference ID/Investigator# 26399 | Charleston | South Carolina | 29407 | — |
| Site Reference ID/Investigator# 21590 | Austin | Texas | 78731 | — |
| Site Reference ID/Investigator# 21582 | Austin | Texas | 78754 | — |
| Site Reference ID/Investigator# 26406 | DeSoto | Texas | 75115 | — |
| Site Reference ID/Investigator# 26402 | Houston | Texas | 77008 | — |
| Site Reference ID/Investigator# 27502 | Bellevue | Washington | 98007 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01077700, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 5, 2018 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01077700 live on ClinicalTrials.gov.